Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.36 |
| ▸ | MYC | P01106 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.35 |
| ▸ | CECR2 | Q9BXF3 | 1/20 | 0.35 |
| ▸ | STAT3 | P40763 | 1/20 | 0.35 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.35 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7769435 | 0.87 | ALDH1A1 (0.41) | KDM4EGRM4ALDH1A1ALOX12MEN1 | |
| SCHEMBL27471377 | 0.85 | MYC (0.51) | KDM4EGRM4ALDH1A1POLBTP53 | |
| SCHEMBL5137956 | 0.82 | ALDH1A1 (0.36) | GRM4ALDH1A1ALOX12MEN1KMT2A | |
| SCHEMBL30358600 | 0.80 | ALDH1A1 (0.39) | KDM4EALDH1A1ALOX12MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL21800936 | 0.79 | GRM4 (0.39) | KDM4EGRM4ALDH1A1MEN1KMT2A | |
| SCHEMBL1232653 | 0.76 | MAPK1 (0.38) | KDM4EALDH1A1MEN1KMT2AMAPT | |
| SCHEMBL567033 | 0.76 | KDM4E (0.38) | KDM4EGRM4ALDH1A1MEN1KMT2A | |
| SCHEMBL317626 | 0.74 | CA12 (0.42) | KDM4EGRM4KMT2ATP53MYC | |
| SCHEMBL26799 | 0.74 | KMT2A (0.58) | KDM4EALDH1A1MEN1KMT2AATM | |
| SCHEMBL2898289 | 0.74 | CA12 (0.35) | KDM4EALDH1A1KMT2ATP53HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3999 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025151464-A1 | ALPHA-PARTICLE RADIONUCLIDE-ANTIBODY CONJUGATES FOR TREATMENT OF SOLID TUMORS | THE JOHNS HOPKINS UNIVERSITY (US) | 2025-07-17 | — | — | WO | claimed |
| WO-2025083205-A1 | DRUG COMBINATION COMPRISING ANTI-CD37 ANTIBODY MAYTANSINE CONJUGATE AND BCL2 INHIBITOR OR PI3K INHIBITOR | DEBIOPHARM INTERNATIONAL S.A. (CH) | 2025-04-24 | — | — | WO | claimed |
| US-20240238432-A1 | METHOD FOR GLYCOPROTEIN MODIFICATION | HONEYBEAR BIOSCIENCES INC. (TW) | 2024-07-18 | — | — | US | claimed |
| WO-2024151999-A1 | POLYMERIZED HEMOGLOBIN SIZE FRACTIONATED VIA TANGENTIAL FLOW FILTRATION | OHIO STATE INNOVATION FOUNDATION (US) | 2024-07-18 | — | — | WO | claimed |
| US-20240226312-A1 | TREATMENT OF CANCER IN PATIENTS WITH SOLUBLE FR-ALPHA | IMMUNOGEN, INC. (US) | 2024-07-11 | — | — | US | claimed |
| WO-2024145600-A1 | METHOD FOR GLYCOPROTEIN MODIFICATION | HONEYBEAR BIOSCIENCES INC. (TW) | 2024-07-04 | — | — | WO | claimed |
| EP-4347661-A1 | TREATMENT OF CANCER IN PATIENTS WITH SOLUBLE FR-ALPHA | ImmunoGen, Inc. (US) | 2024-04-10 | — | — | EP | claimed |
| EP-3218410-B1 | ANTIBODY DRUG CONJUGATES | NOVARTIS AG (CH) | 2024-03-27 | — | — | EP | claimed |
| EP-4313009-A1 | MAYTANSINE-ANTIBODY CONJUGATES AND METHODS OF USING SAME | Angiex, Inc. (US) | 2024-02-07 | — | — | EP | claimed |
| EP-4309671-A2 | METHODS FOR INCREASING EFFICACY OF FOLR1 CANCER THERAPY | ImmunoGen, Inc. (US) | 2024-01-24 | — | — | EP | claimed |
| US-5492893-A | STERILIZATION OF ANIMALS; THERAPY OD SEX HORMONE RELATEDDISEASES | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1996-02-20 | — | — | US | claimed |
| US-5488036-A | GONADOTROPHINS IN CELLS FOR POLYPEPTIDE HORMONES | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1996-01-30 | — | — | US | claimed |
| US-5378688-A | Conjugating luteinizing hormone releasing hormone to plant, bacterialo or chemical toxins | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1995-01-03 | — | — | US | claimed |
| EP-0591369-A1 | CAPSID FORMING AND CYSTEIN MODIFIED CHIMAERIC MS2-COAT PROTEIN | BTG INTERNATIONAL LIMITED (GB) | 1994-04-13 | — | — | EP | claimed |
| EP-0366770-B1 | LIPOSOMES COUPLED TO HORMONES | VESTAR INC (US) | 1994-02-09 | — | — | EP | claimed |
| WO-1994000600-A1 | SOLID SUPPORTS FOR NUCLEIC ACID HYBRIDIZATION ASSAYS | MICROPROBE CORPORATION (US) | 1994-01-06 | — | — | WO | claimed |
| WO-1993000434-A1 | CAPSID FORMING AND CYSTEIN MODIFIED CHIMAERIC MS2-COAT PROTEIN | BRITISH TECHNOLOGY GROUP LTD. (GB) | 1993-01-07 | — | — | WO | claimed |
| EP-0196669-B1 | IMPROVED METHOD OF CONJUGATING METALLOTHIONEIN TO BIOLOGICALLY ACTIVE MOLECULES | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1992-02-12 | — | — | EP | claimed |
| US-5077210-A | Binding of proteins for use as biosensors, bioassays | SCIENCE APPLICATIONS INTERNATIONAL CORPORATION | 1991-12-31 | — | — | US | claimed |
| US-4218539-A | COUPLING ENZYMES WITH MACROMOLECULES FOR IMMUNOASSAY | WELTMAN JOEL K | 1980-08-19 | — | — | US | claimed |